Meyka Pro banner
Mobia Medical, Inc. Common Stock

Mobia Medical, Inc. Common Stock Fundamental Analysis (NASDAQ: MOBI)

MOBINASDAQ
HealthcareMedical - Specialties
$10.25
$0.57(5.27%)
U.S. Market opens in 12h 48m

Mobia Medical, Inc. Common Stock Fundamental Analysis (NASDAQ: MOBI)

Mobia Medical, Inc. Common Stock (NASDAQ: MOBI) shows weak financial fundamentals with a PE ratio of -6.39, profit margin of -1.52%, and ROE of -15.96%. The company generates $0.0B in annual revenue with weak year-over-year growth of 0.00%.

Key Strengths

Cash Position90.51%
PEG Ratio-0.06
Current Ratio13.28

Areas of Concern

ROE-15.96%
Operating Margin-1.36%
We analyze MOBI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -1682.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-1682.6/100

We analyze MOBI's fundamental strength across five key dimensions:

Efficiency Score

Weak

MOBI struggles to generate sufficient returns from assets.

ROA > 10%
-19.86%

Valuation Score

Excellent

MOBI trades at attractive valuation levels.

PE < 25
-6.39
PEG Ratio < 2
-0.06

Growth Score

Weak

MOBI faces weak or negative growth trends.

Revenue Growth > 5%
0.00%
EPS Growth > 10%
0.00%

Financial Health Score

Excellent

MOBI maintains a strong and stable balance sheet.

Debt/Equity < 1
0.05
Current Ratio > 1
13.28

Profitability Score

Weak

MOBI struggles to sustain strong margins.

ROE > 15%
-1595.68%
Net Margin ≥ 15%
-1.52%
Positive Free Cash Flow
No

Key Financial Metrics

Is MOBI Expensive or Cheap?

P/E Ratio

MOBI trades at -6.39 times earnings. This suggests potential undervaluation.

-6.39

PEG Ratio

When adjusting for growth, MOBI's PEG of -0.06 indicates potential undervaluation.

-0.06

Price to Book

The market values Mobia Medical, Inc. Common Stock at 1.16 times its book value. This may indicate undervaluation.

1.16

EV/EBITDA

Enterprise value stands at -14.73 times EBITDA. This is generally considered low.

-14.73

How Well Does MOBI Make Money?

Net Profit Margin

For every $100 in sales, Mobia Medical, Inc. Common Stock keeps $-1.52 as profit after all expenses.

-1.52%

Operating Margin

Core operations generate -1.36 in profit for every $100 in revenue, before interest and taxes.

-1.36%

ROE

Management delivers $-15.96 in profit for every $100 of shareholder equity.

-15.96%

ROA

Mobia Medical, Inc. Common Stock generates $-19.86 in profit for every $100 in assets, demonstrating efficient asset deployment.

-19.86%

Following the Money - Real Cash Generation

Operating Cash Flow

Mobia Medical, Inc. Common Stock generates limited operating cash flow of $-58.17M, signaling weaker underlying cash strength.

$-58.17M

Free Cash Flow

Mobia Medical, Inc. Common Stock generates weak or negative free cash flow of $-60.93M, restricting financial flexibility.

$-60.93M

FCF Per Share

Each share generates $-1.83 in free cash annually.

$-1.83

FCF Yield

MOBI converts -10.18% of its market value into free cash.

-10.18%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-6.39

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.06

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.16

vs 25 benchmark

P/S Ratio

Price to sales ratio

13.62

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.05

vs 25 benchmark

Current Ratio

Current assets to current liabilities

13.28

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-15.96

vs 25 benchmark

ROA

Return on assets percentage

-0.20

vs 25 benchmark

ROCE

Return on capital employed

-0.19

vs 25 benchmark

How MOBI Stacks Against Its Sector Peers

MetricMOBI ValueSector AveragePerformance
P/E Ratio-6.3931.00 Better (Cheaper)
ROE-1595.68%524.00% Weak
Net Margin-151.62%21528.00% Weak
Debt/Equity0.050.53 Strong (Low Leverage)
Current Ratio13.285.64 Strong Liquidity
ROA-19.86%-104.00% (disorted) Weak

MOBI outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Mobia Medical, Inc. Common Stock's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ